Laurent Peyrin‐Biroulet

机构：Inserm, McGill University Health Centre, Centre Hospitalier Régional et Universitaire de Nancy, Centre d’Investigation Clinique Innovation Technologique de Nancy, Délégation Centre-Est, Northwestern Medicine, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine · ORCID：0000-0003-2536-6618

发表论文 2074 篇 · 总被引 89966 次 · h-index 139

代表论文

Precision nutrition for the prevention and management of inflammatory bowel disease (2026 · Nature Reviews Gastroenterology & Hepatology · 被引 2)
Beyond class effects: moving towards drug-level precision in inflammatory bowel disease therapy (2026 · Nature Reviews Gastroenterology & Hepatology · 被引 2)
Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach (2026 · Expert Opinion on Emerging Drugs · 被引 1)
Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumption (2026 · Gut · 被引 1)
Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn’s disease risk (2026 · medRxiv · 被引 1)
Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review (2026 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 1)